TY - JOUR AU - Vilar, L. AU - Freitas, M. C. AU - Naves, L. A. AU - Casulari, L. A. PY - 2008 DA - 2008// TI - Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients JO - J Endocrinol Investig VL - 31 UR - https://doi.org/10.1007/BF03346388 DO - 10.1007/BF03346388 ID - Vilar2008 ER - TY - JOUR AU - Vilar, L. AU - Abucham, J. AU - Albuquerque, J. L. AU - Araujo, L. A. PY - 2018 DA - 2018// TI - Controversial issues in the management of hyperprolactinemia and prolactinomas - an overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism JO - Arch Endocrinol Metab VL - 62 UR - https://doi.org/10.20945/2359-3997000000032 DO - 10.20945/2359-3997000000032 ID - Vilar2018 ER - TY - JOUR AU - Molitch, M. E. PY - 2014 DA - 2014// TI - Management of medically refractory prolactinoma JO - J Neurooncol VL - 117 UR - https://doi.org/10.1007/s11060-013-1270-8 DO - 10.1007/s11060-013-1270-8 ID - Molitch2014 ER - TY - JOUR AU - Oh, M. C. AU - Aghi, M. K. PY - 2011 DA - 2011// TI - Dopamine agonist-resistant prolactinomas: a review JO - J Neurosurg VL - 114 UR - https://doi.org/10.3171/2010.11.JNS101369 DO - 10.3171/2010.11.JNS101369 ID - Oh2011 ER - TY - JOUR AU - Vroonen, L. AU - Jaffrain-Rea, M. L. AU - Petrossians, P. PY - 2012 DA - 2012// TI - Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients JO - Eur J Endocrinol VL - 167 UR - https://doi.org/10.1530/EJE-12-0236 DO - 10.1530/EJE-12-0236 ID - Vroonen2012 ER - TY - JOUR AU - Feldkamp, J. AU - Santen, R. AU - Harms, E. AU - Aulich, A. AU - Modder, U. AU - Scherbaum, W. A. PY - 1999 DA - 1999// TI - Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas – results of a prospective study JO - Clin Endocrinol VL - 51 UR - https://doi.org/10.1046/j.1365-2265.1999.00748.x DO - 10.1046/j.1365-2265.1999.00748.x ID - Feldkamp1999 ER - TY - JOUR AU - Kaltsas, G. A. AU - Evanson, J. AU - Chrisoulidou, A. AU - Grossman, A. B. PY - 2008 DA - 2008// TI - The diagnosis and management of parasellar tumours of the pituitary JO - Endocr Relat Cancer VL - 15 UR - https://doi.org/10.1677/ERC-08-0170 DO - 10.1677/ERC-08-0170 ID - Kaltsas2008 ER - TY - JOUR AU - Vasilev, V. AU - Rostomyan, L. AU - Daly, A. F. PY - 2016 DA - 2016// TI - Management of endocrine disease: pituitary “incidentaloma”: neurological assessment and differential diagnosis JO - Eur J Endocrinol VL - 175 UR - https://doi.org/10.1530/EJE-15-1272 DO - 10.1530/EJE-15-1272 ID - Vasilev2016 ER - TY - JOUR AU - Delgrange, E. AU - Daems, T. AU - Verhelst, J. AU - Abs, R. AU - Maiter, D. PY - 2009 DA - 2009// TI - Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients JO - Eur J Endocrinol VL - 160 UR - https://doi.org/10.1530/EJE-09-0012 DO - 10.1530/EJE-09-0012 ID - Delgrange2009 ER - TY - JOUR AU - Colao, A. AU - Sarno, A. AU - Landi, M. L. PY - 1997 DA - 1997// TI - Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage JO - J Clin Endocrinol Metab VL - 82 UR - https://doi.org/10.1210/jcem.82.11.4368 DO - 10.1210/jcem.82.11.4368 ID - Colao1997 ER - TY - JOUR AU - Sarno, A. AU - Landi, M. L. AU - Cappabianca, P. PY - 2001 DA - 2001// TI - Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy JO - J Clin Endocrinol Metab VL - 86 UR - https://doi.org/10.1210/jcem.86.11.8054 DO - 10.1210/jcem.86.11.8054 ID - Sarno2001 ER - TY - JOUR AU - Ono, M. AU - Miki, N. AU - Kawamata, T. PY - 2008 DA - 2008// TI - Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients JO - J Clin Endocrinol Metab VL - 93 UR - https://doi.org/10.1210/jc.2007-2758 DO - 10.1210/jc.2007-2758 ID - Ono2008 ER - TY - JOUR AU - Barake, M. AU - Evins, A. E. AU - Stoeckel, L. PY - 2014 DA - 2014// TI - Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study JO - Pituitary VL - 17 UR - https://doi.org/10.1007/s11102-013-0480-6 DO - 10.1007/s11102-013-0480-6 ID - Barake2014 ER - TY - JOUR AU - Miu, D. K. AU - Yeung, J. C. PY - 2013 DA - 2013// TI - Incidence of post-stroke delirium and 1-year outcome JO - Geriatr Gerontol Int VL - 13 UR - https://doi.org/10.1111/j.1447-0594.2012.00871.x DO - 10.1111/j.1447-0594.2012.00871.x ID - Miu2013 ER - TY - JOUR AU - Kpelao, E. AU - Beketi, K. A. AU - Moumouni, A. K. PY - 2016 DA - 2016// TI - Clinical profile of subdural hematoma: dangerousness of subacute subdural hematoma JO - Neurosurg Rev VL - 39 UR - https://doi.org/10.1007/s10143-015-0669-4 DO - 10.1007/s10143-015-0669-4 ID - Kpelao2016 ER - TY - JOUR AU - Bostwick, J. R. AU - Guthrie, S. K. AU - Ellingrod, V. L. PY - 2009 DA - 2009// TI - Antipsychotic-induced hyperprolactinemia JO - Pharmacotherapy VL - 29 UR - https://doi.org/10.1592/phco.29.1.64 DO - 10.1592/phco.29.1.64 ID - Bostwick2009 ER - TY - JOUR AU - Liu, J. AU - Sun, J. AU - Shen, X. PY - 2014 DA - 2014// TI - Randomized controlled trial comparing changes in serum prolactin and weight among female patients with first-episode schizophrenia over 12 months of treatment with risperidone or quetiapine JO - Shanghai Arch Psychiatry VL - 26 ID - Liu2014 ER - TY - JOUR AU - Park, Y. M. AU - Lee, S. H. AU - Lee, B. H. PY - 2016 DA - 2016// TI - Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: a preliminary study JO - Psychiatry Res VL - 239 UR - https://doi.org/10.1016/j.psychres.2016.03.015 DO - 10.1016/j.psychres.2016.03.015 ID - Park2016 ER - TY - JOUR AU - Kunwar, A. R. AU - Megna, J. L. PY - 2003 DA - 2003// TI - Resolution of risperidone-induced hyperprolactinemia with substitution of quetiapine JO - Ann Pharmacother VL - 37 UR - https://doi.org/10.1177/106002800303700208 DO - 10.1177/106002800303700208 ID - Kunwar2003 ER - TY - JOUR AU - Schüle, C. AU - Baghai, T. AU - Goy, J. AU - Bidlingmaier, M. AU - Strasburger, C. AU - Laakmann, G. PY - 2002 DA - 2002// TI - The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects JO - Psychopharmacology VL - 163 UR - https://doi.org/10.1007/s00213-002-1148-5 DO - 10.1007/s00213-002-1148-5 ID - Schüle2002 ER - TY - JOUR AU - Schmid, D. A. AU - Wichniak, A. AU - Uhr, M. PY - 2006 DA - 2006// TI - Changes of sleep architecture spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine JO - Neuropsychopharmacology VL - 31 UR - https://doi.org/10.1038/sj.npp.1300923 DO - 10.1038/sj.npp.1300923 ID - Schmid2006 ER - TY - JOUR AU - Chouinard, G. AU - Samaha, A. N. AU - Chouinard, V. A. PY - 2017 DA - 2017// TI - Antipsychotic-induced dopamine supersensitivity psychosis: pharmacology, criteria, and therapy JO - Psycother Psychosom VL - 86 UR - https://doi.org/10.1159/000477313 DO - 10.1159/000477313 ID - Chouinard2017 ER - TY - JOUR AU - Gupta, R. AU - Gupta, K. AU - Tripathi, A. K. AU - Bhatia, M. S. AU - Gupta, L. K. PY - 2016 DA - 2016// TI - Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-α in patients of major depressive disorder with severe depression JO - Pharmacology VL - 97 UR - https://doi.org/10.1159/000444220 DO - 10.1159/000444220 ID - Gupta2016 ER - TY - JOUR AU - Li, H. AU - Hong, W. AU - Zhang, C. PY - 2015 DA - 2015// TI - IL-23 and TGFβ1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode JO - J Affect Disord VL - 174 UR - https://doi.org/10.1016/j.jad.2014.12.033 DO - 10.1016/j.jad.2014.12.033 ID - Li2015 ER - TY - JOUR AU - Wu, J. L. AU - Qiao, J. Y. AU - Duan, Q. H. PY - 2016 DA - 2016// TI - Significance of TNF-α and IL-6 expression in invasive pituitary adenomas JO - Genet Mol Res VL - 15 ID - Wu2016 ER - TY - JOUR AU - Prossin, A. R. AU - Zalcman, S. S. AU - Evans, S. J. AU - McInnis, M. G. AU - Ellingrod, V. L. PY - 2013 DA - 2013// TI - A pilot study investigating TNF-α as a potential intervening variable of atypical antipsychotic associated metabolic syndrome in bipolar disorder JO - Ther Drug Monit VL - 35 UR - https://doi.org/10.1097/FTD.0b013e31827e18d2 DO - 10.1097/FTD.0b013e31827e18d2 ID - Prossin2013 ER - TY - JOUR AU - Recouvreux, M. V. AU - Camilletti, M. A. AU - Rifkin, D. B. AU - Diaz-Torga, G. PY - 2016 DA - 2016// TI - The pituitary TGF β1 system as a novel target for the treatment of resistant prolactinomas JO - J Endocrinol VL - 228 UR - https://doi.org/10.1530/JOE-15-0451 DO - 10.1530/JOE-15-0451 ID - Recouvreux2016 ER - TY - JOUR AU - Auriemma, R. S. AU - Pivonello, R. AU - Perone, Y. PY - 2013 DA - 2013// TI - Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas JO - Eur J Endocrinol VL - 169 UR - https://doi.org/10.1530/EJE-13-0231 DO - 10.1530/EJE-13-0231 ID - Auriemma2013 ER - TY - JOUR AU - Caputo, C. AU - Prior, D. AU - Inder, W. J. PY - 2015 DA - 2015// TI - The need for annual echocardiography to detect cabergoline-associated valvulopathy in patients with prolactinoma: a systematic review and additional clinical data JO - Lancet Diabetes Endocrinol VL - 3 UR - https://doi.org/10.1016/S2213-8587(14)70212-8 DO - 10.1016/S2213-8587(14)70212-8 ID - Caputo2015 ER -